Tenax Therapeutics Inc (NASDAQ: TENX) — Healthcare · Share Price, Chart & Market Data
About: Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.65 (+9.44%)
TENXTenax Therapeutics Inc
Loading watchlist status…
Trade TENX now
Tenax Therapeutics Inc share price
TENX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:57 pm GMT+0
TENX price performance
14.401%
5D
5.034%
1M
41.629%
YTD
166.546%
1Y
TENX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:57 pm GMT+0
TENX details
TENX Market Signals